Lista de obras - John H Beigel - Dominio Público Uruguay

"Differential risk of hospitalization among single virus infections causing influenza-like illnesses"

artículo científico publicado en 2018

2081. Building a Decision Tree with Serial Serology Measurements Improves Classification in a Flavivirus Co-circulation Region

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

artículo científico publicado en 2016

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

artículo científico publicado en 2015

A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells

artículo científico publicado en 2011

A study in scarlet-convalescent plasma for severe influenza*.

artículo científico publicado en 2012

A unique immune signature of serum cytokine and chemokine dynamics in patients with zika virus infection from a tropical region in Southern Mexico

scientific article published on 17 February 2020

ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.

artículo científico publicado en 2010

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference

scientific article published on 08 April 2019

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

artículo científico publicado en 2020

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

scientific article published on 30 September 2019

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2019

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

scholarly article by Nicole Doria-Rose published in 2021

Avian influenza A (H5N1) infection in humans

artículo científico publicado en 2005

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

scientific article published on 11 December 2020

Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease

artículo científico publicado en 2004

Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations

article

Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City

artículo científico publicado en 2013

Clinical characteristics of asthmatic patients with influenza-like illness and risk of severe exacerbations in Mexico.

artículo científico publicado en 2016

Comparison of Rates of Hospitalization Between Single and Dual Virus Detection in a Mexican Cohort of Children and Adults With Influenza-Like Illness

artículo científico publicado en 2019

Comparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico

artículo científico publicado en 2021

Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas Mexico

artículo científico publicado en 2021

Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.

artículo científico publicado en 2017

Current and future antiviral therapy of severe seasonal and avian influenza

artículo científico publicado en 2008

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

artículo científico publicado en 2016

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome

artículo científico publicado en 2019

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

artículo científico publicado en 2020

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

artículo científico publicado en 2021

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

artículo científico publicado en 2021

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial

artículo científico publicado en 2019

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness

article by Ana E Gamiño-Arroyo et al published 1 November 2019 in Clinical Infectious Diseases

Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico

artículo científico publicado en 2016

Erratum: IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.

artículo científico publicado en 2016

Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

artículo científico publicado en 2007

Hark back: passive immunotherapy for influenza and other serious infections.

artículo científico publicado en 2010

Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies

artículo científico publicado en 2016

Hydrocortisone and fludrocortisone improved 28-day survival in septic shock and adrenal insufficiency.

artículo científico publicado en 2003

IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity

artículo científico publicado en 2016

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

artículo científico publicado en 2017

Implications of weight and body mass index for plasma donation and health

artículo científico publicado en 2012

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays

artículo científico publicado en 2018

Influenza

article

Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances

artículo científico publicado en 2020

Interpreting diagnostic studies in SARS--defining the reference

artículo científico publicado en 2004

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

artículo científico publicado en 2017

Penicillium citrinum: Opportunistic pathogen or idle bystander? A case analysis with demonstration of galactomannan cross-reactivity.

artículo científico publicado en 2017

Polyclonal and monoclonal antibodies for the treatment of influenza

artículo científico publicado en 2018

Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference

artículo científico publicado en 2017

Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico

artículo científico publicado en 2019

Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data

artículo científico publicado en 2007

Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply

scientific article published on 10 July 2020

Remdesivir for the Treatment of Covid-19 — Final Report

artículo científico publicado en 2020

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

artículo científico publicado en 2020

Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.

artículo científico publicado en 2009

Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.

artículo científico publicado en 2010

Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study

artículo científico publicado en 2018

Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation

artículo científico publicado en 2017

Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area

scientific article published on 28 October 2019

The emerging utility of neopterin?

artículo científico publicado en 2005

The role of adjuvant immunomodulatory agents for treatment of severe influenza

artículo científico publicado en 2018

Toward better clinical data in emerging infectious diseases

artículo científico publicado en 2009

Transparent development of the WHO rapid advice guidelines

artículo científico publicado en 2007

Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses

artículo científico publicado en 2018

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

artículo científico publicado en 2007

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies

artículo científico publicado en 2011

Lista de obras de John H Beigel

"Differential risk of hospitalization among single virus infections causing influenza-like illnesses"

2081. Building a Decision Tree with Serial Serology Measurements Improves Classification in a Flavivirus Co-circulation Region

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells

A study in scarlet-convalescent plasma for severe influenza*.

A unique immune signature of serum cytokine and chemokine dynamics in patients with zika virus infection from a tropical region in Southern Mexico

ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Avian influenza A (H5N1) infection in humans

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease

Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations

Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City

Clinical characteristics of asthmatic patients with influenza-like illness and risk of severe exacerbations in Mexico.

Comparison of Rates of Hospitalization Between Single and Dual Virus Detection in a Mexican Cohort of Children and Adults With Influenza-Like Illness

Comparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico

Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas Mexico

Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.

Current and future antiviral therapy of severe seasonal and avian influenza

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness

Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico

Erratum: IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.

Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Hark back: passive immunotherapy for influenza and other serious infections.

Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies

Hydrocortisone and fludrocortisone improved 28-day survival in septic shock and adrenal insufficiency.

IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

Implications of weight and body mass index for plasma donation and health

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays

Influenza

Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances

Interpreting diagnostic studies in SARS--defining the reference

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Penicillium citrinum: Opportunistic pathogen or idle bystander? A case analysis with demonstration of galactomannan cross-reactivity.

Polyclonal and monoclonal antibodies for the treatment of influenza

Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference

Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico

Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data

Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply

Remdesivir for the Treatment of Covid-19 — Final Report

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.

Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.

Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study

Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation

Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area

The emerging utility of neopterin?

The role of adjuvant immunomodulatory agents for treatment of severe influenza

Toward better clinical data in emerging infectious diseases

Transparent development of the WHO rapid advice guidelines

Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies